267 filings
Page 5 of 14
8-K
4cf24c2a
23 Dec 19
Departure of Directors or Certain Officers
4:43pm
8-K
x2aez6po
26 Nov 19
Bio-path Holdings Announces Successful Completion of Safety Testing In Stage 2 of Phase 2 Clinical Trial In Acute Myeloid Leukemia
4:30pm
8-K
q5pedsy850v ls
22 Nov 19
Entry into a Material Definitive Agreement
5:25pm
8-K
0qngibax0t9
21 Nov 19
Bio-path Holdings Announces Clearance of Investigational New Drug Application for BP1002
8:20am
8-K
mp6 3i9h3x2w4
15 Nov 19
Bio-path Holdings Reports Third Quarter 2019 Financial Results
7:05am
8-K
gq3hp
15 Oct 19
Bio-Path Holdings Appoints Martina Molsbergen to Board of Directors
4:23pm
8-K
t76xx29rz
25 Sep 19
Bio-Path Updates Intellectual Property Portfolio with Addition of Recently Issued Second Platform Technology Patent
5:16pm
8-K
rjyczakykmcbyqhp3
4 Sep 19
Bio-Path Holdings to Present at the H.C. Wainwright 21st Annual Global Investment Conference
4:06pm
8-K
grjhtd61b7da2k14d1a
26 Aug 19
Bio-Path Announces Patient Dosing in Amended Phase 2 Prexigebersen Trial in Acute Myeloid Leukemia
9:33pm
8-K
owjhi1m0zlyqoailber
15 Aug 19
Bio-path Holdings Reports Second Quarter 2019 Financial Results
7:05am
8-K
v9a2mgk0457vr
4 Jun 19
Entry into a Material Definitive Agreement
4:30pm
8-K
4yam30
16 May 19
Bio-path Holdings Reports First Quarter 2019 Financial Results
7:05am
8-K
0ksaw3o5 8r
3 Apr 19
Bio-Path Holdings Presents Preclinical Data at American Association for Cancer Research Annual Meeting 2019
4:30pm
8-K
oxu9wg ewy72gf3ovm7
20 Mar 19
Bio-path Holdings Reports Full Year 2018 Financial Results
7:00am
8-K
90d6z8jq43ubvpqvl
13 Mar 19
Entry into a Material Definitive Agreement
4:24pm
8-K
jvhgngurr8zb2x4k
6 Mar 19
Bio-Path Announces Clinical Update to Interim Analysis of Phase 2 Prexigebersen Trial in Acute Myeloid Leukemia
4:30pm
8-K
q8jqy7ezxu7rn i9rnz
28 Feb 19
Bio-Path Holdings to Present Data at the 2019 AACR Annual Meeting
4:30pm
8-K
9o27 3k2usl
5 Feb 19
Other Events
4:30pm
8-K
sreavf2syiq
22 Jan 19
Entry into a Material Definitive Agreement
4:46pm
8-K
bfxe0r
16 Jan 19
Bio-Path Holdings, Inc. Announces Proposed Public Offering of Common Stock
5:25pm